Economists saw “limited” risk to the pharmaceutical firm’s stock, despite some expected impact on Tylenol consumption.
4don MSN
Tylenol maker Kenvue plunges on reports that the White House planned to link the drug to autism
The White House is reportedly planning to link Tylenol use during pregnancy to autism. The news pushed Kenvue stock down 8%.
Shares may be rising because investors expected the White House to announce stricter regulations on the medication, Citi ...
Earlier this week, the Trump administration publicly warned of a possible link between prenatal Tylenol use and autism, ...
President Donald Trump is set to speak today on how Tylenol may be linked to autism. Here's when, who makes Tylenol, and ...
Analysts saw no new scientific evidence from the White House to support President Donald Trump linking Tylenol to autism.
Independent, sound science clearly shows that taking acetaminophen does not cause autism,” a Kenvue spokesperson told ...
Kenvue is the over-the-counter products company that was spun out of Johnson & Johnson in 2023. Tylenol, one of the most ...
Kenvue stock dropped following reports of a possible autism link to Tylenol's active ingredient, acetaminophen. Federal ...
Kenvue shares rebounded after a sharp fall triggered by Donald Trump's unfounded claims linking Tylenol to autism. Trump ...
Tylenol maker Kenvue ‘strongly disagrees’ there is a causal link between acetaminophen use during pregnancy and autism.
Shares of Tylenol maker Kenvue are dropping in morning trading Monday on a report that the White House is expected to make an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results